Phase 2 Start~month

Phase 2 Start: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of OPK-88006 in Healthy and Presumed

Indication
MASH

Other upcoming events for OPK

Patent ExpiryPatent/Exclusivity Expiry: RAYALDEE

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Start: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of OPK-88006 in Healthy and Presumed — OPK Phase 2 Start | BioSniper